Why Indian Immunologicals Ltd?

Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. IIL operates one of the largest plants in the world for veterinary vaccines. IIL has adequate infrastructure and cold chain distribution capability to reach out to various parts of India and world market.

What is the difference between IIL Gachibowli and IIL karakapatla?

The Gachibowli-Hyderabad facility is engaged in the production of vaccines, while the Karakapatla-Hyderabad facility produces animal health formulations and human vaccines. IIL’s facility in Ooty exclusively produces human anti-rabies vaccine, “Abhayrab”.

Why choose animal health manufacturing at IIL?

The Animal Health Manufacturing facilities at IIL are certified and world-class. We keep the veterinarian experts abreast with the latest research and upcoming technologies in the domain.

Why Human Biologicals Institute of India?

IIL established Human Biologicals Institute (HBI) in 1999 to manufacture modern Tissue Culture Anti Rabies Vaccine (TCARV) for human use at Ooty, Tamil Nadu. IIL exports its products to more than 50 countries across the world with a customer focus in Middle East, Asia, Africa, CISR countries and expanding in Central and Latin America.

Indian Immunologicals Ltd (IIL) was created by National Dairy Development Board (NDDB) under the Operation Flood program with objective of improving livestock health in India in 1982. Today, IIL is the third largest animal health player in the Indian market and the market leader in veterinary biologicals in India.

What is the authorized share capital of Indian Immunologicals Limited?

It’s authorized share capital is INR 15.00 cr and the total paid-up capital is INR 9.00 cr. Indian Immunologicals Limited’s operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2020.

When was Indian Immunologicals Limited’s annual general meeting last held?

Indian Immunologicals Limited’s Annual General Meeting (AGM) was last held on 18 September 2020 and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2020.

Which is the largest veterinary biological company in India?

IIL is the largest veterinary biological company in India with a range of vaccines for cattle, sheep and canine segments. Combined with its presence in the formulations segment, IIL holds the third position in the Indian animal health market.